‹ All Posts
Prameela Balakkala

9th May · SEBI-Registered Analyst

MCX Q4 FY26: Profit Quadruples, Margins Soar, Dividend Declared

MCX
📊 Financial Performance Net Profit: ₹5.3B vs ₹1.35B YoY (↑292%). Revenue: ₹8.89B vs ₹2.9B YoY (↑206%). EBITDA: ₹6.67B vs ₹1.6B YoY (↑317%). EBITDA Margin: 74.8% vs 55.0% YoY (massive margin expansion). Dividend: Final dividend of ₹8 per share declared. 📈 Key Financial Ratios Net Profit Margin: ~59.6% (exceptionally strong). EBITDA Margin: 74.8% (reflects high operating leverage). ROE: ~20–22% (boosted by profit surge). ROCE: ~18–20% (efficient capital deployment). Debt-to-Equity: Very low, MCX operates with minimal leverage. Interest Coverage Ratio: Extremely strong, virtually debt-free. ✅ Fundamentals Market Leadership: India’s largest commodity derivatives exchange. Revenue Surge: Driven by higher trading volumes in bullion, energy, and base metals. Profit Growth: Net profit nearly quadrupled YoY, reflecting strong operational efficiency. Cash Flow Strength: High margins and liquidity enable consistent dividend payouts. Regulatory Backing: Operates under SEBI oversight, ensuring credibility. 🏗️ Projects & Expansion Technology Upgrade: New trading platform launched to improve speed and reliability. Product Diversification: Expanding contracts in bullion, energy, agri commodities, and indices. Retail Participation: Initiatives to attract more retail investors into commodity trading. Global Partnerships: Exploring collaborations for cross-border commodity contracts. Digital Initiatives: AI-driven analytics and risk management tools for traders. ⚠️ Risks & Challenges Regulatory Risks: Commodity trading subject to strict SEBI norms. Market Volatility: Earnings tied to trading volumes, which fluctuate with global commodity cycles. Competition: NSE and BSE expanding commodity derivatives offerings. Global Factors: Crude oil, gold, and currency volatility directly impact trading activity.

#Today’sTradingSetup#StockInNews#Miscellaneous#EquityResearch#PersonalFinance
1,088 likes·59 comments